INS and Alzheimer disease: Notably, it was found that defective insulin signaling in the brain of AD patients may contribute to synaptic damage and cognitive deficits, and that normalization of insulin signaling may be beneficial (Gralle, 2017; Ferrario and Reagan, 2018).